[HTML][HTML] Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study
Background Bell's palsy is a rare adverse event reported in clinical trials of COVID-19
vaccines. However, to our knowledge no population-based study has assessed the …
vaccines. However, to our knowledge no population-based study has assessed the …
[PDF][PDF] Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study
EYF Wan, CSL Chui, FTT Lai, EWY Chan, X Li… - Lancet Infect …, 2022 - researchgate.net
Background Bell's palsy is a rare adverse event reported in clinical trials of COVID-19
vaccines. However, to our knowledge no population-based study has assessed the …
vaccines. However, to our knowledge no population-based study has assessed the …
Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study
EYF Wan, CSL Chui, FTT Lai… - The Lancet …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Bell's palsy is a rare adverse event reported in clinical trials of COVID-19
vaccines. However, to our knowledge no population-based study has assessed the …
vaccines. However, to our knowledge no population-based study has assessed the …
Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study
EYF Wan, CSL Chui, FTT Lai, EWY Chan… - The Lancet …, 2022 - discovery.ucl.ac.uk
BACKGROUND: Bell's palsy is a rare adverse event reported in clinical trials of COVID-19
vaccines. However, to our knowledge no population-based study has assessed the …
vaccines. However, to our knowledge no population-based study has assessed the …
[引用][C] Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study
EYF Wan, CSL Chui, FTT Lai, EWY Chan, X Li… - The Lancet Infectious …, 2022 - cir.nii.ac.jp
Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac)
SARS-CoV-2 vaccines: a case series and nested case-control study | CiNii Research CiNii 国立 …
SARS-CoV-2 vaccines: a case series and nested case-control study | CiNii Research CiNii 国立 …
[HTML][HTML] Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study
EYF Wan, CSL Chui, FTT Lai, EWY Chan… - The Lancet. Infectious …, 2022 - ncbi.nlm.nih.gov
Background Bell's palsy is a rare adverse event reported in clinical trials of COVID-19
vaccines. However, to our knowledge no population-based study has assessed the …
vaccines. However, to our knowledge no population-based study has assessed the …
Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study.
EYF Wan, CSL Chui, FTT Lai, EWY Chan… - The Lancet. Infectious …, 2021 - europepmc.org
Background Bell's palsy is a rare adverse event reported in clinical trials of COVID-19
vaccines. However, to our knowledge no population-based study has assessed the …
vaccines. However, to our knowledge no population-based study has assessed the …
Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study
EYF Wan, CSL Chui, FTT Lai, EWY Chan… - The Lancet Infectious …, 2022 - covid19.sld.cu
Background Bell's palsy is a rare adverse event reported in clinical trials of COVID-19
vaccines. However, to our knowledge no population-based study has assessed the …
vaccines. However, to our knowledge no population-based study has assessed the …
Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study
EYF Wan, CSL Chui, FTT Lai, EWY Chan, X Li… - The Lancet Infectious …, 2022 - Elsevier
Background Bell's palsy is a rare adverse event reported in clinical trials of COVID-19
vaccines. However, to our knowledge no population-based study has assessed the …
vaccines. However, to our knowledge no population-based study has assessed the …
[HTML][HTML] Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study
EYF Wan, CSL Chui, FTT Lai, EWY Chan… - The Lancet Infectious …, 2022 - thelancet.com
Background Bell's palsy is a rare adverse event reported in clinical trials of COVID-19
vaccines. However, to our knowledge no population-based study has assessed the …
vaccines. However, to our knowledge no population-based study has assessed the …